Handelsavisen
prelaunch
Companies Healthcare 6493.TWO
64
6493.TWO TPEx Medical Equipment, Supplies & Distribution

6493.Two

$29,90
Open in Charts → Attach watcher ⌖
TWD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
898,5M TWD
P/E
EV / Rev
Div yield
0,00 %
Op margin
-5,3 %
ROE
-6,0 %
Net margin
-5,3 %
Debt / equity
0,49
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

6493.TWO operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

Business. 6493.TWO operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-6,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 6493.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 6493.TWO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    6493.TWO operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company's capital structure shows a debt-to-equity ratio of 0.49, indicating a relatively conservative leverage position. However, the liquidity position is marked by a negative net cash position after subtracting total debt, which raises concerns about short-term financial flexibility. The price-to-book ratio of 2.36 suggests that the market values the company at a premium to its book value, but the negative return on equity of -5.96% and return on assets of -3.42% indicate poor profitability relative to its capital base.

    Profitability metrics are significantly below industry norms, with a negative operating income of -21.23 million TWD and a net loss of -2.13 million TWD. The company's gross profit margin of 17.63% is also underperforming compared to the industry's median, which typically exceeds 25%. These figures suggest that the company is struggling to convert its revenue into sustainable profits, which could be a red flag for investors.

    The company's revenue is not segmented by product or geographic region in the available data, making it difficult to assess the concentration of risk in specific markets or product lines. However, the negative operating cash flow of -4.10 million TWD and the free cash flow of 2.08 million TWD indicate that the company is not generating sufficient cash from operations to support its capital expenditures or debt obligations.

    Looking ahead, the company's growth trajectory is uncertain, as the available data does not provide forward-looking revenue guidance or outlook for the next fiscal year. The negative operating income and net loss suggest that the company may need to implement cost-cutting measures or find new revenue streams to improve its financial performance. The capital expenditure of -6.65 million TWD indicates that the company is investing in its operations, but the negative operating cash flow raises questions about the sustainability of these investments.

    The risk assessment highlights a medium liquidity risk due to the negative net cash position after subtracting total debt. The dilution risk is currently low, but the company's financial performance and cash flow issues could increase the likelihood of future dilution if it needs to raise additional capital. The risk of dilution is further compounded by the company's negative net income and the potential need for further financing to support its operations.

    Recent events and filings do not provide specific details about the company's strategic initiatives or financial performance beyond the reported financials. The lack of detailed information on recent events or management discussions makes it challenging to assess the company's response to market conditions or its long-term strategy. Investors should monitor the company's financial reports and any new disclosures for insights into its future direction.

    Key takeaways
    • The company is operating at a loss with a negative return on equity and return on assets, indicating poor profitability.
    • The debt-to-equity ratio is relatively low, but the negative net cash position raises liquidity concerns.
    • The company's financial performance is below industry norms, with a low gross profit margin and negative operating income.
    • The lack of detailed segment and geographic revenue data makes it difficult to assess the concentration of risk in specific markets or product lines.
    • The company's growth trajectory is uncertain, and it may need to implement cost-cutting measures or find new revenue streams to improve its financial performance.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $29,90
    Market cap
    $842.9M
    Enterprise value
    $964.3M
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    2.4x
    P / Tangible book
    2.4x
    Tangible book
    $357.4M
    Net cash
    -$121.4M
    Current ratio
    2.4
    Debt / equity
    0.5
    ROA
    -3.4%
    ROE
    -6.0%
    Cash conversion
    193.0%
    CapEx / revenue
    -1.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-5,3 %Below median
    Net Margin-5,3 %Below median
    ROE-6,0 %Below median
    Capex / Rev-1,7 %Above P75
    D/E0,49Below median
    Cash Conv1,93Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    Source documents
    • 6493.TWO Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    6493.TWOCanonical
    TPEx · TWD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage